| ID | Name | CAS | Properties |
logPoct/wat |
| 18-921-9 |
7,8,9,10-Tetrahydro-6H-cyclohepta[d]pyrido[1,2-a]pyrimidin-11-one
|
|
3 | 2.606 |
| 18-998-5 |
3H-Pyrazol-3-one, 2,4-dihydro-2,5-dimethyl-
|
2749-59-9 |
3 | 0.224 |
| 19-052-3 |
(9Z,11E)-Hexadeca-9,11-dien-1-ol, adduct with 4-methyl-3,5-dihydro-1,2,4-triazole-3,5-dione
|
|
3 | 2.914 |
| 19-101-8 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, butyl ester
|
|
3 | 4.920 |
| 19-223-3 |
3-Ethyl-2-isopropyl-3,5-dimethyl-1,4,2-diazaphosphorine-2-oxide
|
|
3 | 4.645 |
| 19-257-6 |
O-Ethyl-O-(1,1-difluoro-2-bromoethyl)-N-propyl-phosphorothioamidate
|
|
3 | 3.251 |
| 19-309-8 |
Spirocyclohexane-2-(1,5,6-triazabicyclo[3.1.0]hexane), 4,4,6-tris(trifluoromethyl)-
|
130720-67-1 |
3 | 4.450 |
| 19-472-7 |
1,3-Cyclobutanediimine, n,n'-dicyclohexyl-2,2,4,4-tetramethyl
|
|
3 | 5.600 |
| 19-532-0 |
N,n-dimethyl-p-methyl phosphonamidic acid, n-propyl ester
|
|
3 | 1.797 |
| 19-562-7 |
1,3,5(10)-Oestratriene-2,3,17.beta.-triol, 2,3-TMS-17-HFB
|
|
3 | 8.715 |
| 19-648-2 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, isohexyl ester
|
|
3 | 4.105 |
| 19-666-2 |
cis-N-(1-Bicyclo[2.2.1]heptyl)-N'-(1-bicyclo[2.2.2]octyl)diazene
|
|
3 | 4.494 |
| 19-671-6 |
1,3,5(10)-Oestratriene-2-methoxy-3,17«beta»-diol, 3-TBDMS-17-HFB
|
|
3 | 8.680 |
| 19-705-8 |
allo-Cholanic acid, 3«beta»,7«beta»,12«beta»-trihydroxy, Me-DMES
|
|
3 | 10.285 |
| 19-865-1 |
Naphtho[1,8',8:c,d]cyclodeca-1,5-diiyne
|
|
3 | 3.727 |
| 20-180-9 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-ethenyl
|
|
3 | 3.160 |
| 20-217-8 |
Di[1,1'-biphenyl]-2-yl 4-(1-phenylethyl)phenyl phosphate
|
116402-02-9 |
3 | 10.817 |
| 20-274-5 |
[(1R)-7-(Hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] hexanoate
|
|
3 | 1.733 |
| 20-406-8 |
N-(2-Hydroxy-propionyl)-4-methyl-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
3 | 3.587 |
| 20-445-5 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, pentyl ester
|
|
3 | 3.698 |
| 20-740-7 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5-dimethyl-7,7-tetramethylene
|
|
3 | 0.684 |
| 20-826-2 |
24-Nor-5«beta»-cholane-3«alpha»,7«alpha»,23-triol, TMS
|
|
3 | 9.573 |
| 20-849-7 |
Irgacure 369 (2-Benzyl-2-(dimethylamino)-1-[4-(morpholinyl) phenyl)]-1-butanone)
|
|
3 | 3.659 |
| 21-019-7 |
Thiazolo[3,2-a]pyridinium, 3-hydroxy-2-phenyl-, hydroxide, inner salt
|
|
3 | 2.227 |
| 21-039-5 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, isohexyl ester
|
|
3 | 3.944 |
| 21-246-5 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5,6-trimethyl
|
|
3 | -0.287 |
| 21-300-4 |
Phosphoric acid, 2-(diethylamino)-6-methyl-4-pyrimidinyl diethyl ester
|
|
3 | 3.191 |
| 21-497-7 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-allyl-phosphorothioamidate
|
|
3 | 2.871 |
| 21-616-4 |
Pyridine, 1,1'-[1,2-phenylenebis(1-oxo-2,1-ethanediyl)]bis[1,2,3,4-tetrahydro-
|
|
3 | 3.044 |
| 21-695-7 |
allo-Cholanic acid, 3«alpha»,7«beta»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 21-745-1 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, butyl ester
|
|
3 | 3.308 |
| 22-150-0 |
5,5-Dimethyl-2-phenyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1.963 |
| 22-200-4 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine-4,13(14H)-dione, decahydro-, [7S-(7«alpha»,7a«beta»,14«alpha»,14a«alpha»)]-
|
|
3 | 1.398 |
| 22-377-9 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro-6-methyl
|
|
3 | 1.882 |
| 22-392-2 |
Cyclopentyl-hydroxy-phenyl-acetic acid 1-methyl-pyrrolidin-3-yl ester
|
|
3 | 2.312 |
| 22-415-6 |
Thiazolo[3,2-a]pyridinium, 8-hydroxy-3-methyl-, hydroxide, inner salt
|
30276-99-4 |
3 | 0.869 |
| 22-588-5 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 2,2-tetramethylene hydrazide
|
|
3 | -0.023 |
| 22-957-5 |
4H-cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro
|
|
3 | 1.183 |
| 23-018-6 |
Thiazolo[3,2-a]pyridinium, 2,3-dihydro-8-hydroxy-5-methyl-, hydroxide, inner salt
|
23003-43-2 |
3 | 0.462 |
| 23-150-9 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17«beta»-ol, monoTMS
|
|
3 | 6.495 |
| 23-171-6 |
2,5,5-Trimethyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 0.935 |
| 23-277-9 |
4-Quinolinol,1-ethyl-4-ethynyldecahydro-2-methyl-(2«alpha»,4«beta»,4a«alpha»,8a«beta»)
|
38463-55-7 |
3 | 2.024 |
| 23-932-1 |
2,6-Pyridinedicarboxylic acid, 1-methoxydec-4-yl propyl ester
|
|
3 | 4.571 |
| 23-954-7 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro
|
|
3 | 0.580 |
| 24-071-6 |
Imidazole, 2,3-dihydro-1-methyl-2-acetylimino-3-acetyl-4acetyloxy-
|
|
3 | -0.141 |
| 24-647-7 |
allo-Cholanic acid, 3«beta»,7«alpha»,12«alpha»-trihydroxy, Me-DMES
|
|
3 | 10.285 |
| 24-886-2 |
4-CHLORO-3-(3-METHYL-5-OXO-2-PYRAZOLIN-1-YL)BENZENESULFONIC ACID
|
|
3 | 1.699 |
| 24-913-1 |
2-Pyrazoline, 4,4-dimethyl-5-(1-methylethyl), 1-benzoyl
|
|
3 | 3.179 |
| 25-006-7 |
Silanamine, 1,1,1-trimethyl-N-[4-[(trimethylsilyl)oxy]phenyl]-
|
52726-86-0 |
3 | 4.147 |
| 25-019-3 |
2,3,5,6,7,8-Hexahydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
88491-50-3 |
3 | 1.068 |
| 25-181-3 |
2-Methyl-5,5-pentamethylene-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1.859 |
| 25-282-1 |
[(7R)-7-Hydroxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl hexanoate
|
|
3 | 1.485 |
| 25-289-4 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»-ol (stigmastanol), DMESI
|
|
3 | 10.354 |
| 25-753-8 |
O-Ethyl-O-(1,1-difluoro-2-bromoethyl)-N-metyl-phosphorothioamidate
|
|
3 | 2.471 |
| 25-842-9 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, isobutyl ester
|
|
3 | 3.325 |
| 25-902-2 |
1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, decahydro-
|
18161-94-9 |
3 | 0.607 |
| 25-971-6 |
2-Amino-4,6-dihydroxypyrimidine, N,O,O'-tris(pentafluoropropionyl)-
|
|
3 | 3.819 |
| 26-069-7 |
2,6-Pyridinedicarboxylic acid, 2-methylbutyl 2-methylhex-3-yl ester
|
|
3 | 4.266 |
| 26-538-6 |
Thiazolo[3,2-a]pyridinium, 8-hydroxy-3,5-dimethyl-, hydroxide, inner salt
|
|
3 | 1.177 |
| 26-677-2 |
(Z)-10-Dodecenoic acid, 9,12-dioxo, methyl ester, bis-PFB-oxime, # 1
|
|
3 | 7.613 |
| 26-737-5 |
5«alpha»-Pregnane-3«alpha»,20«alpha»,21-triol, TMS
|
|
3 | 8.937 |
| 26-784-3 |
cis-N-(1-Bicyclo[2.2.1]heptyl-N'-(1-adamantyl)diazene
|
|
3 | 4.740 |
| 26-810-3 |
3,3,7,7-Tetramethyl-1,5-diazabicyclo[3.3.0]octane
|
2940-98-9 |
3 | 1.585 |
| 27-368-4 |
allo-Cholanic acid, 7«alpha»,12«alpha»-dihydroxy, Me-DMES
|
|
3 | 9.065 |
| 27-489-0 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin-4-one, 1,2,3,7,9,10,11,13,14,14a-decahydro-, [7S-(7«alpha»,14«alpha»,14a«alpha»)]-
|
35611-60-0 |
3 | 1.997 |
| 27-524-0 |
4-Quinolinol, 4-ethyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«alpha»,8a«beta»)-
|
20422-70-2 |
3 | 2.410 |
| 27-724-8 |
3,4-Dihydro-3,3-dimethyl-2-p-tolyl-2H-1,4,2-benzoxazaphosphorine-2-oxide
|
|
3 | 4.139 |
| 27-752-7 |
5-Pregnen-3-«beta»-ol-11,20-dione, MO-TMS
|
|
3 | 6.420 |
| 27-825-6 |
allo-Cholanic acid, 3«alpha»,7«alpha»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 27-834-6 |
Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1S-[1«alpha»,7(2R*,3R*),7a«alpha»]]-
|
480-83-1 |
3 | -0.327 |
| 27-941-7 |
Furan-3-carboxylic acid, 4-methyl-2-(2-methoxycarbonylethyl)-5-(4-hydroxypentyl), methyl ester
|
|
3 | 2.184 |
| 27-970-5 |
5-«beta»-Pregnan-20-«alpha»-ol-3-one, MO-TMS
|
|
3 | 6.888 |
| 28-380-9 |
5-«alpha»-Androstan-3-«alpha»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 6.038 |
| 28-396-2 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl-7,7-pentamethylene
|
|
3 | 1.074 |
| 28-430-3 |
4-Quinolinol,4-ethenyl-1-ethyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«alpha»,8a«beta»)
|
38463-57-9 |
3 | 2.576 |
| 28-574-4 |
2-(N-n-hexyl-n-n-octylamino)-3-(n-nonyl) pyrazine
|
116402-86-9 |
3 | 8.517 |
| 28-768-9 |
2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-benzo[1,3]dioxol-5-yl-propan-1-ol, TMS
|
|
3 | 5.185 |
| 28-866-0 |
1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-1,3,7-trimethyl-
|
|
3 | -2.218 |
| 29-109-9 |
N-(5,6-Dichloro-1,3-benzothiazol-2-yl)acetamide
|
|
3 | 3.562 |
| 29-171-0 |
Acetamide, N-phenyl-N-[1-(1-phenyl-2-propyl)-4-piperidinyl]-
|
90736-19-9 |
3 | 4.308 |
| 29-281-8 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro-6-methyl-
|
|
3 | 1.141 |
| 29-375-4 |
4-Quinolinol, 4-ethynyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
14788-65-9 |
3 | 1.634 |
| 29-453-7 |
[(3R)-7-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (E)-3-methylpent-2-enoate
|
|
3 | 1.482 |
| 29-716-5 |
4-Quinolinol,1-ethyl-4-ethynyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«beta»,8a«alpha»)
|
38463-56-8 |
3 | 2.024 |
| 29-886-7 |
5-«beta»-Cholestan-3-«beta»,7-«alpha»,12-«alpha»-triol, TMS
|
|
3 | 10.988 |
| 29-986-6 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
20431-95-2 |
3 | 2.186 |
| 30-026-9 |
4-Quinolinol, 4-ethyldecahydro-1,2-dimethyl-, (2«alpha»,4«beta»,4a«alpha»,8a«beta»)-
|
20422-72-4 |
3 | 2.410 |
| 30-247-4 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 9-methyl
|
|
3 | 1.003 |
| 30-334-7 |
1-(P-chlorophenyl)-3-(o-hydroxyphenyl)-2-propen-1-oxime
|
116557-94-9 |
3 | 3.937 |
| 30-400-3 |
5,5'-Diphenyl-[2,2'-azo-1,3,4-thiadiazole]
|
101279-08-7 |
3 | 5.139 |
| 30-619-1 |
2-Amino-4,6-dihydroxypyrimidine, N,O,O'-tris(trifluoroacetyl)-
|
|
3 | 1.913 |
| 30-948-6 |
allo-Cholanic acid, 3«alpha»,7«alpha»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 31-179-9 |
«alpha»-D-Xylopyranose, 1,2,3,4-tetrakis-O-(trimethylsilyl)-
|
14251-20-8 |
3 | 4.854 |
| 31-195-1 |
Thiazolo[3,2-a]pyridinium,3,8-dihydroxy-,hydroxide,inner salt
|
35143-55-6 |
3 | 0.266 |
| 31-300-3 |
N-(1,2-Dimethylpropyl)-N,N-bis(heptafluorobutyryl)-N'-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 5.990 |
| 31-530-8 |
2,6-Pyridinedicarboxylic acid, isopropyl 2-methylhex-3-yl ester
|
|
3 | 3.628 |
| 31-696-5 |
Cholanic acid, 3«alpha»,7«alpha»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 31-791-9 |
5-Acetamino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile
|
|
3 | 4.655 |
| 31-952-0 |
2-([(Dimethylamino)methylene]amino)-3-(3-chloro-4-butyloxy-phenyl)propanoic acid, butyl ester
|
|
3 | 4.363 |
| 31-960-1 |
2-(2,4-Dichlorophenyl)-1-(1,2,4-triazol-1-yl)hexan-2-ol, trimethylsilyl ether
|
|
3 | 5.522 |
|
« Previous Results
Next Results »
|